Filana Therapeutics, Inc.
MX ˙ BMV ˙ US14817C1071
SecurityMX:FLNA / Filana Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership17,990 shares
Latest Disclosed Value $ 30,404
Morgan Stanley reports 74.46% decrease in ownership of FLNA / Filana Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 17,990 shares of Filana Therapeutics, Inc. (MX:FLNA) valued at $30,404 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 70,439 shares of Filana Therapeutics, Inc.. This represents a change in shares of -74.46% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F FILANA THERAPEUTICS COM 14817C107 17,990 -52,449 -74.46 30 -78.42 0.0000
2026-05-27 2025-12-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 70,439 -279,621 -79.88 139 -86.35 0.0000
2026-02-13 2025-12-31 13F CASSAVA SCIENCES COM 14817C107 70,439 -279,621 139 0.0000
2026-05-27 2025-09-30 13F/A-1 CASSAVA SCIENCES COM 14817C107 350,060 -100,487 -22.30 1,019 24.91 0.0001
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM 14817C107 350,060 -100,487 1,019 0.0001
2025-08-15 2025-06-30 13F CASSAVA SCIENCES COM 14817C107 450,547 74,197 19.71 815 44.50 0.0001
2025-05-15 2025-03-31 13F CASSAVA SCIENCES COM 14817C107 376,350 110,160 41.38 565 -10.19 0.0000
2025-05-15 2024-12-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 266,190 -253,354 -48.76 628 -95.89 0.0000
2025-02-14 2024-12-31 13F CASSAVA SCIENCES COM 14817C107 266,190 -253,354 628 0.0000
2025-05-14 2024-09-30 13F/A-2 CASSAVA SCIENCES COM 14817C107 519,544 356,217 218.10 15,290 658.06 0.0011
2025-02-14 2024-09-30 13F/A-1 CASSAVA SCIENCES COM 14817C107 519,544 356,217 15,290 0.0011
2024-11-14 2024-09-30 13F CASSAVA SCIENCES COM 14817C107 519,544 356,217 15,290 0.0011
2025-05-14 2024-06-30 13F/A-2 CASSAVA SCIENCES COM 14817C107 163,327 -41,094 -20.10 2,017 -51.36 0.0002
2024-10-17 2024-06-30 13F/A-1 CASSAVA SCIENCES COM 14817C107 163,327 -41,094 2,017 0.0002
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM 14817C107 163,327 -41,094 2,017 0.0002
2024-10-17 2024-03-31 13F/A-2 CASSAVA SCIENCES COM 14817C107 204,421 -336,852 -62.23 4,148 -65.96 0.0003
2024-08-16 2024-03-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 204,421 -336,852 4,148 0.0003
2024-05-15 2024-03-31 13F CASSAVA SCIENCES COM 14817C107 204,421 -336,852 4,148 0.0003
2024-08-16 2023-12-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 541,273 108,032 24.94 12,184 69.01 0.0011
2024-02-13 2023-12-31 13F CASSAVA SCIENCES COM 14817C107 541,273 108,032 12,184 0.0011
2023-11-15 2023-09-30 13F CASSAVA SCIENCES COM 14817C107 433,241 262,092 153.14 7,209 71.81 0.0007
2023-08-14 2023-06-30 13F CASSAVA SCIENCES COM 14817C107 171,149 18,696 12.26 4,197 14.11 0.0004
2023-05-15 2023-03-31 13F CASSAVA SCIENCES COM 14817C107 152,453 -62,982 -29.23 3,677 -42.21 0.0004
2023-02-14 2022-12-31 13F CASSAVA SCIENCES COM 14817C107 215,435 -2,508 -1.15 6,364 -30.19 0.0007
2022-11-14 2022-09-30 13F CASSAVA SCIENCES COM 14817C107 217,943 1,446 0.67 9,115 49.75 0.0012
2022-10-27 2022-06-30 13F/A-1 CASSAVA SCIENCES COM 14817C107 216,497 68,822 46.60 6,087 11.00 0.0008
2022-08-15 2022-06-30 13F CASSAVA SCIENCES COM 14817C107 216,497 68,822 6,087 0.0008
2022-10-27 2022-03-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 147,675 -407,013 -73.38 5,484 -77.38 0.0007
2022-05-13 2022-03-31 13F CASSAVA SCIENCES COM 14817C107 147,675 -407,013 5,484 0.0007
2022-02-14 2021-12-31 13F CASSAVA SCIENCES COM 14817C107 554,688 200,219 56.48 24,239 10.15 0.0030
2021-11-15 2021-09-30 13F CASSAVA SCIENCES COM 14817C107 354,469 191,738 117.83 22,006 58.28 0.0030
2021-08-23 2021-06-30 13F/A-1 CASSAVA SCIENCES COM 14817C107 162,731 -60,631 -27.14 13,903 38.48 0.0018
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM 14817C107 162,731 -60,631 13,903 0.0018
2021-05-17 2021-03-31 13F CASSAVA SCIENCES COM 14817C107 223,362 172,250 337.01 10,040 2,785.06 0.0015
2021-02-16 2020-12-31 13F CASSAVA SCIENCES COM 14817C107 51,112 17,539 52.24 348 -9.84 0.0001
2020-11-13 2020-09-30 13F CASSAVA SCIENCES COM 14817C107 33,573 4,440 15.24 386 328.89 0.0001
2020-08-14 2020-06-30 13F CASSAVA SCIENCES COM 14817C107 29,133 -33,971 -53.83 90 -65.38 0.0000
2020-05-26 2020-03-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 63,104 56,811 902.76 260 687.88 0.0001
2020-05-15 2020-03-31 13F CASSAVA SCIENCES COM 14817C107 63,104 56,811 260 70.5280
2020-02-14 2019-12-31 13F CASSAVA SCIENCES COM 14817C107 6,293 -422 -6.28 33 312.50 0.0000
2019-11-14 2019-09-30 13F CASSAVA SCIENCES COM 14817C107 6,715 -422 -5.91 8 -11.11 0.0000
2019-08-14 2019-06-30 13F CASSAVA SCIENCES COM 14817C107 7,137 422 6.28 9 0.00 0.0000
2019-05-15 2019-03-31 13F CASSAVA SCIENCES COM 14817C107 6,715 0 0.00 9 50.00 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.